TACSTD2 and renal pelvis/ureter urothelial carcinoma: The mutation frequencies of the ADC targets nectin-4, encoded by the NECTIN4 gene, and TROP2, the gene product of TACSTD2, are close to 0% in primary UTUC tumors (Figure 1).